Webinars and events

« All Events

This event has passed.

Interpreting genetic risk loci from GWAS in the context of key genes and pathways using QIAGEN Ingenuity Pathway Analysis

Details

Date:
August 10, 2023
Time:
1:00 pm - 2:30 pm
Website:
REGISTER FOR EVENT
Event Categories:
,
Event Tags:
, ,

Venue

Virtual - Americas - EST
United States

August 10, 2023 @ 1:00 pm - 2:30 pm

Start time where you are: Your time zone couldn't be detected. Try reloading the page.

Genome-wide association studies (GWAS) provide insights into the genetic architecture of disease by identifying susceptibility loci for the disease within a population. If you'd like to identify disease genes and novel biological pathways that underlay the disease pathogenesis to identify novel drug targets, QIAGEN Ingenuity Pathway Analysis (IPA) helps you characterize and validate risk loci within a biological context. In this training, you'll discover how to perform a core analysis for a list of risk loci to study their association with different pathways and regulatory networks.

You'll learn how to:
• Upload and perform a core analysis on a list of GWAS risk loci
• Investigate pathways and regulatory networks to understand biological mechanisms
• Compare enrichment between risk loci analysis to identify biological similarities and difference
• Identify commonalities and differences between risk loci list
• Generate a custom network and contextualize it using public data
• Export high-resolution images and comprehensive tabular results in preferred formats

On-demand Webinars

Network construction and customization with QIAGEN Ingenuity Pathway Analysis
This in-depth training focuses on effectively constructing a network, with or without a dataset (RNA-seq, proteomics, etc.), and easily modifying it – all within Ingenuity Pathway Analysis. In this interactive training, attendees will learn how to: • Construct a network from scratch or open a network/pathway of interest from their analysis or the Ingenuity Knowl...
WATCH NOW
QIAGEN Biomedical KB-HD: data- and analytics-driven drug discovery
Ingenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, a...
WATCH NOW
Clinician’s Roundtable: Interpreting genomic test results for precision oncology
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medici...
WATCH NOW
Leveraging the power of API-based omics (RNA-seq, proteomics and more) queries for discovery
There is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, exper...
WATCH NOW
Scale up NGS bioinformatics analysis throughput with CLC Genomics Server and Cloud solutions
More and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics Workbench can be ...
WATCH NOW
Streamline H5N1 and other microbial samples with CLC Genomics Workbench
In this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: • Utilize molec...
WATCH NOW

Tissue-specific target identification using QIAGEN OmicSoft high-quality ‘omics data

WATCH NOW

Identifying critical drug-to-disease pathways using high-quality curated literature and ‘omics data

WATCH NOW

Single-cell RNA-seq, cell hashing and spatial transcriptomics

WATCH NOW

Discoveries from deeply curated TCGA expression data using OmicSoft Studio

WATCH NOW

Sanger sequencing, alignment, cloning, primer design and more using QIAGEN CLC Main and Genomics Workbench

WATCH NOW

Support Session for IPA Certification

WATCH NOW
1 2 3 84
Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.